Analgesics (Pharmacies) - Africa | Statista Market Forecast

Revenue in the Analgesics market is projected to reach US$1.46bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.14%, resulting in a market volume of US$2.16bn by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$1.12 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Africa is experiencing significant growth due to several factors.

Customer preferences: Customers in Africa have shown a growing preference for analgesics purchased from pharmacies. This is primarily due to the trust and reliability associated with pharmacy products. Consumers in Africa are increasingly seeking professional advice and guidance when it comes to managing their pain, and pharmacies provide a convenient and accessible source for analgesics. Additionally, the wide range of analgesic products available in pharmacies allows customers to choose the most suitable option for their specific needs.

Trends in the market: One major trend in the Analgesics (Pharmacies) market in Africa is the increasing demand for over-the-counter (OTC) analgesics. OTC analgesics are medications that can be purchased without a prescription, and they are becoming increasingly popular among consumers in Africa. This trend can be attributed to several factors, including the convenience of purchasing OTC products without the need for a doctor's visit, the lower cost compared to prescription medications, and the increasing awareness and knowledge about self-care and managing minor ailments. Another trend in the market is the rising demand for natural and herbal analgesics. African consumers are becoming more health-conscious and are seeking alternative and natural remedies for pain relief. This trend is driven by the perception that natural and herbal products are safer and have fewer side effects compared to conventional analgesics. As a result, pharmacies in Africa are expanding their product offerings to include a variety of natural and herbal analgesics to cater to this growing demand.

Local special circumstances: The Analgesics (Pharmacies) market in Africa is also influenced by local special circumstances. One such circumstance is the prevalence of certain diseases and health conditions that require regular pain management. For example, Africa has a high burden of infectious diseases such as malaria and HIV/AIDS, which can cause chronic pain. This creates a constant demand for analgesics in the region. Additionally, the lack of access to healthcare facilities in many parts of Africa means that pharmacies often serve as the primary point of care for communities. This further drives the demand for analgesics in pharmacies, as they are often the only source of medication for pain relief in these areas.

Underlying macroeconomic factors: Several macroeconomic factors contribute to the development of the Analgesics (Pharmacies) market in Africa. The continent's growing population and increasing disposable income levels are key drivers of market growth. As more people are able to afford healthcare services, the demand for analgesics in pharmacies is expected to rise. Furthermore, urbanization and the expansion of the middle class in Africa are also contributing to the growth of the market. As more people move to cities and experience improved living standards, they are more likely to seek healthcare services from pharmacies, including pain management. In conclusion, the Analgesics (Pharmacies) market in Africa is experiencing growth due to customer preferences for pharmacy products, the increasing demand for OTC and natural analgesics, local special circumstances such as the prevalence of certain diseases, and underlying macroeconomic factors such as population growth and rising disposable incomes.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.